Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43


FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements.

Lutgring JD, Machado MJ, Benahmed FH, Conville P, Shawar RM, Patel J, Brown AC.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01415-17. doi: 10.1128/JCM.01415-17. Print 2018 Feb.


The Complexities of Nocardia Taxonomy and Identification.

Conville PS, Brown-Elliott BA, Smith T, Zelazny AM.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01419-17. doi: 10.1128/JCM.01419-17. Print 2018 Jan. Review.


Multicenter Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Study for Identification of Clinically Relevant Nocardia spp.

Blosser SJ, Drake SK, Andrasko JL, Henderson CM, Kamboj K, Antonara S, Mijares L, Conville P, Frank KM, Harrington SM, Balada-Llasat JM, Zelazny AM.

J Clin Microbiol. 2016 May;54(5):1251-8. doi: 10.1128/JCM.02942-15. Epub 2016 Feb 24.


New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance.

Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM.

J Clin Microbiol. 2013 Sep;51(9):2943-9. doi: 10.1128/JCM.01132-13. Epub 2013 Jun 26.


Adaptability and persistence of the emerging pathogen Bordetella petrii.

Zelazny AM, Ding L, Goldberg JB, Mijares LA, Conlan S, Conville PS, Stock F, Ballentine SJ, Olivier KN, Sampaio EP, Murray PR, Holland SM.

PLoS One. 2013 Jun 4;8(6):e65102. doi: 10.1371/journal.pone.0065102. Print 2013.


Genomic insights into the emerging human pathogen Mycobacterium massiliense.

Tettelin H, Sampaio EP, Daugherty SC, Hine E, Riley DR, Sadzewicz L, Sengamalay N, Shefchek K, Su Q, Tallon LJ, Conville P, Olivier KN, Holland SM, Fraser CM, Zelazny AM.

J Bacteriol. 2012 Oct;194(19):5450. doi: 10.1128/JB.01200-12.


Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.

Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, Killian SB, Knapp CC, Warshauer D, Van T, Wengenack NL, Deml S, Woods GL.

J Clin Microbiol. 2012 Apr;50(4):1270-80. doi: 10.1128/JCM.00994-11. Epub 2012 Jan 4.


Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.

Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, Wengenack N, Kriel K, Bridge L, McNulty S, Vasireddy R, Wallace RJ Jr.

J Clin Microbiol. 2012 Mar;50(3):670-2. doi: 10.1128/JCM.06243-11. Epub 2011 Dec 14.


Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.

Davis JL, Huang L, Worodria W, Masur H, Cattamanchi A, Huber C, Miller C, Conville PS, Murray P, Kovacs JA.

PLoS One. 2011 Jan 27;6(1):e16321. doi: 10.1371/journal.pone.0016321.


Evaluation of the integrated database network system (IDNS) SmartGene software for analysis of 16S rRNA gene sequences for identification of Nocardia species.

Conville PS, Murray PR, Zelazny AM.

J Clin Microbiol. 2010 Aug;48(8):2995-8. doi: 10.1128/JCM.00681-10. Epub 2010 Jun 23.


Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates.

Ripamonti C, Orenstein A, Kutty G, Huang L, Schuhegger R, Sing A, Fantoni G, Atzori C, Vinton C, Huber C, Conville PS, Kovacs JA.

J Infect Dis. 2009 Nov 15;200(10):1616-22. doi: 10.1086/644643.


Nocardia iowensis sp. nov., an organism rich in biocatalytically important enzymes and nitric oxide synthase.

Lamm AS, Khare A, Conville P, Lau PC, Bergeron H, Rosazza JP.

Int J Syst Evol Microbiol. 2009 Oct;59(Pt 10):2408-14. doi: 10.1099/ijs.0.007427-0. Epub 2009 Jul 21.


"Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen.

Palmore TN, Shea YR, Conville PS, Witebsky FG, Anderson VL, Rupp Hodge IP, Holland SM.

J Clin Microbiol. 2009 May;47(5):1585-7. doi: 10.1128/JCM.02385-08. Epub 2009 Mar 4.


Nocardia cyriacigeorgica--an established rather than an emerging pathogen.

Witebsky FG, Conville PS, Wallace RJ Jr, Brown-Elliott BA, Huard RC, Schlaberg R, Della-Latta P.

J Clin Microbiol. 2008 Jul;46(7):2469; author reply 2469-70. doi: 10.1128/JCM.00510-08. No abstract available.


Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex".

Conville PS, Brown JM, Steigerwalt AG, Brown-Elliott BA, Witebsky FG.

J Clin Microbiol. 2008 Apr;46(4):1178-84. doi: 10.1128/JCM.02011-07. Epub 2008 Feb 6.


Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae.

Greenberg DE, Porcella SF, Stock F, Wong A, Conville PS, Murray PR, Holland SM, Zelazny AM.

Int J Syst Evol Microbiol. 2006 Nov;56(Pt 11):2609-16.


Analysis of secA1 gene sequences for identification of Nocardia species.

Conville PS, Zelazny AM, Witebsky FG.

J Clin Microbiol. 2006 Aug;44(8):2760-6.


Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr.

Clin Microbiol Rev. 2006 Apr;19(2):259-82. Review.


Nocardia kruczakiae sp. nov., a pathogen in immunocompromised patients and a member of the "N. nova complex".

Conville PS, Brown JM, Steigerwalt AG, Lee JW, Anderson VL, Fishbain JT, Holland SM, Witebsky FG.

J Clin Microbiol. 2004 Nov;42(11):5139-45.


Evaluation of partial 16S ribosomal DNA sequencing for identification of nocardia species by using the MicroSeq 500 system with an expanded database.

Cloud JL, Conville PS, Croft A, Harmsen D, Witebsky FG, Carroll KC.

J Clin Microbiol. 2004 Feb;42(2):578-84.


"Too numerous to count" lesions on magnetic resonance images of the brain.

Dass K, Shoham S, Monsein L, Conville PS, Witebsky FG, Lucey DR.

Clin Infect Dis. 2003 Jun 15;36(12):1545-6, 1606-8. No abstract available.


Nocardia veterana as a pathogen in North American patients.

Conville PS, Brown JM, Steigerwalt AG, Lee JW, Byrer DE, Anderson VL, Dorman SE, Holland SM, Cahill B, Carroll KC, Witebsky FG.

J Clin Microbiol. 2003 Jun;41(6):2560-8. Erratum in: J Clin Microbiol. 2004 Feb;42(2):939.


Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.

Woods GL, Williams-Bouyer N, Wallace RJ Jr, Brown-Elliott BA, Witebsky FG, Conville PS, Plaunt M, Hall G, Aralar P, Inderlied C.

J Clin Microbiol. 2003 Feb;41(2):627-31.


Nocardia infection in chronic granulomatous disease.

Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM.

Clin Infect Dis. 2002 Aug 15;35(4):390-4. Epub 2002 Jul 23.


Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene.

Conville PS, Fischer SH, Cartwright CP, Witebsky FG.

J Clin Microbiol. 2000 Jan;38(1):158-64.


Fatal Nocardia pulmonary infection in a child with acquired immunodeficiency syndrome and lymphoid interstitial pneumonitis.

Zwerski S, Witebsky FG, Conville PS, Gill VJ, Freifeld AG.

Pediatr Infect Dis J. 1997 Nov;16(11):1088-9. No abstract available.


Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.

Polis MA, Piscitelli SC, Vogel S, Witebsky FG, Conville PS, Petty B, Kovacs JA, Davey RT Jr, Walker RE, Falloon J, Metcalf JA, Craft C, Lane HC, Masur H.

Antimicrob Agents Chemother. 1997 Aug;41(8):1709-14.


Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium.

Conville PS, Andrews JW, Witebsky FG.

J Clin Microbiol. 1995 Aug;33(8):2012-5.


Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.

Husson RN, Ross LA, Sandelli S, Inderlied CB, Venzon D, Lewis LL, Woods L, Conville PS, Witebsky FG, Pizzo PA.

J Pediatr. 1994 May;124(5 Pt 1):807-14.


The laboratory diagnosis of mycobacterial diseases.

Witebsky FG, Conville PS.

Infect Dis Clin North Am. 1993 Jun;7(2):359-76. Review.


Inter-bottle transfer of mycobacteria by the BACTEC 460.

Conville PS, Witebsky FG.

Diagn Microbiol Infect Dis. 1989 Sep-Oct;12(5):401-5.


Comparison of three techniques for concentrating positive BACTEC 13A bottles for mycobacterial DNA probe analysis.

Conville PS, Keiser JF, Witebsky FG.

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):309-13.


Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia.

Witebsky FG, Keiser JF, Conville PS, Bryan R, Park CH, Walker R, Siddiqi SH.

J Clin Microbiol. 1988 Aug;26(8):1501-5.


Rapid identification of enterococci by pyrrolidonyl aminopeptidase activity (PYRase).

Mitchell MJ, Conville PS, Gill VJ.

Diagn Microbiol Infect Dis. 1987 Apr;6(4):283-6.


Rapid identification of group A streptococci by the Strep-A-Fluor system.

Wu TC, Williams EC, Conville PS.

Diagn Microbiol Infect Dis. 1987 Jan;6(1):5-9.


A supervisor evaluation form for today's lab.

Conville PS, Andrews JW, Katz GL, Sanford JM.

MLO Med Lab Obs. 1986 Mar;18(3):45-50. No abstract available.


Supplemental Content

Loading ...
Support Center